Brief: Day One Biopharmaceuticals - Expects Cash, Short-Term Investments To Fund Opex Into 2026
12/06/2023 14:45
June 12 (Reuters) - Day One Biopharmaceuticals Inc
DAWN.O :
* DAY ONE BIOPHARMACEUTICALS -EXPECTS CASH, CASH
EQUIVALENTS,
SHORT-TERM INVESTMENTS AS OF MARCH 31 TO ENABLE FUND OPEX, CAPEX
REQUIREMENTS INTO 2026
Further company coverage: DAWN.O
(Reuters.briefs@thomsonreuters.com)